Amplia Therapeutics logo

ATX - Amplia Therapeutics Share Price

A$0.08 0.0  0.0%

Last Trade - 4:56am

Sector
Healthcare
Size
Micro Cap
Market Cap £2.22m
Enterprise Value £1.59m
Revenue £-0.219k
Position in Universe 1635th / 1860
Bullish
Bearish
Unlock ATX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ATX Revenue Unlock ATX Revenue

Net Income

ATX Net Income Unlock ATX Revenue

Normalised EPS

ATX Normalised EPS Unlock ATX Revenue

PE Ratio Range

ATX PE Ratio Range Unlock ATX Revenue

Dividend Yield Range

ATX Dividend Yield Range Unlock ATX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ATX EPS Forecasts Unlock ATX Revenue
Profile Summary

Amplia Therapeutics Limited, formerly Innate Immunotherapeutics Limited, is a pharmaceutical company. The Company is engaged in research and development of immune-oncology drugs and chemotherapies to address serious unmet needs in fibrotic tumors. The Company is focused on advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis, particularly focused on pancreatic and ovarian cancer. Its initial clinical development pipeline comprises of two novel orally available small molecule FAK inhibitors: AMP945 (FAK-only) and AMP886 (FAK/FLT3/VEGFR3).

Directors
Last Annual March 31st, 2019
Last Interim September 30th, 2019
Incorporated October 11, 2013
Public Since December 23, 2013
No. of Shareholders: n/a
No. of Employees: 1
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 53,170,585
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address Level 29 55 Collins Street, MELBOURNE, 3000, Australia
Web http://www.ampliatx.com/
Phone +61 2 80033650
Contact ()
Auditors Grant Thornton Audit Pty Ltd
ATX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ATX
Upcoming Events for ATX
Similar to ATX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.